18th Jun 2014 07:47
LONDON (Alliance News) - Hutchison China MediTech Ltd said Wednesday its majority owned research and development company has begun the first in-human Phase I clinical trial of HMPL-523 for autoimmune diseases. Hutchinson MediPharma Ltd has begun the trial in Australia, with the aim of estab Read More
